Repeated 5-day cycles of low dose aldesleukin in amyotrophic lateral sclerosis (IMODALS): A phase 2a randomised, double-blind, placebo-controlled trialWilliam Camu, Gilbert Bensimon, Cecília Garlanda et al.|EBioMedicine|2020Cited by 81
Amyotrophic lateral sclerosis transcriptomics reveals immunological effects of low-dose interleukin-2Ilaria Giovannelli, Janine Kirby, Nadhim Bayatti et al.|Brain Communications|2021Cited by 28